Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.

Lookup NU author(s): Professor Luke ValeORCiD

Downloads

Licence

This is the final published version of an article that has been published in its final definitive form by National Coordinating Centre for Health Technology Assessment, 2011.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Hislop J, Quayyum Z, Elders A, Fraser C, Jenkinson D, Mowatt G, Sharma P, Vale L, Petty R

Publication type: Article

Publication status: Published

Journal: Health Technology Assessment

Year: 2011

Volume: 15

Issue: 25

Pages: 178

Print publication date: 01/06/2011

Date deposited: 16/05/2012

ISSN (print): 1366-5278

ISSN (electronic): 2046-4924

Publisher: National Coordinating Centre for Health Technology Assessment

URL: http://www.hta.ac.uk/2154

DOI: 10.3310/hta15250

Altmetrics

Altmetrics provided by Altmetric

Share